Health Canada Looks At Easing Burden Involved With Running Expanded Access Trials

As part of efforts to modernize its clinical trials framework, the Canadian regulator is looking to better facilitate expanded access clinical trials, which allow investigational drugs to reach patients with serious conditions before they are approved.

Close-up of a red map pin on the modern road leading to modern big city. 3D Illustration
Decentralized models can expand the geographic outreach of expanded access trials (Shutterstock)

More from Clinical Trials

More from Geography